Study of DS-1123a in Advanced Solid Tumours

NCT02690337 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignant Tumors

Interventions

DRUG: DS-1123

Sponsor

Daiichi Sankyo Co., Ltd.